Levofloxacin + Ornidazole in pharma franchise in Manipur

Levofloxacin + Ornidazole in PCD pharma franchise in Shillong

Levofloxacin + Ornidazole in top pharma company in Allahabad

Levofloxacin + Ornidazole in pcd pharma supplier in Jabalpur

Levofloxacin + Ornidazole in phama franchise company in India
Levofloxacin + Ornidazole in phama distributor in Gwalior

Home/Products /levofloxacin-125mg-5ml-ornidazole-125mg-5ml-suspension

Lexoziff OZ Suspension

Composition : Levofloxacin (125mg/5ml) + Ornidazole (125mg/5ml)

Dosage Form : Suspension

Packaging Type : with Outer with Measuring Cap

Packaging : 30ml

Price : ₹83/-

Lexoziff OZ Suspension is a broad-spectrum antimicrobial formulation combining Levofloxacin (125mg/5ml) and Ornidazole (125mg/5ml). This dual-action suspension is designed to effectively target a wide range of bacterial and protozoal infections, particularly those affecting the gastrointestinal and respiratory systems.

  • Levofloxacin: A fluoroquinolone antibiotic that inhibits bacterial DNA synthesis, treating respiratory, urinary, and gastrointestinal infections caused by Gram-positive and Gram-negative bacteria.
  • Ornidazole: An antiprotozoal and antibacterial agent effective against anaerobic bacteria and protozoa, addressing infections like amoebiasis, giardiasis, and bacterial dysentery.

This combination is particularly useful for mixed infections, providing a synergistic action against both aerobic and anaerobic pathogens. Lexoziff O Suspension is ideal for pediatric and adult patients requiring precise and effective treatment for infections.

Read More

About the Product

Lexoziff OZ Suspension is a broad-spectrum antimicrobial formulation combining Levofloxacin (125mg/5ml) and Ornidazole (125mg/5ml). This dual-action suspension is designed to effectively target a wide range of bacterial and protozoal infections, particularly those affecting the gastrointestinal and respiratory systems.

  • Levofloxacin: A fluoroquinolone antibiotic that inhibits bacterial DNA synthesis, treating respiratory, urinary, and gastrointestinal infections caused by Gram-positive and Gram-negative bacteria.
  • Ornidazole: An antiprotozoal and antibacterial agent effective against anaerobic bacteria and protozoa, addressing infections like amoebiasis, giardiasis, and bacterial dysentery.

This combination is particularly useful for mixed infections, providing a synergistic action against both aerobic and anaerobic pathogens. Lexoziff O Suspension is ideal for pediatric and adult patients requiring precise and effective treatment for infections.

Common side effects may include nausea, diarrhea, dizziness, headache, or abdominal discomfort. Rarely, allergic reactions or photosensitivity may occur.

Lexoziff OZ Suspension is indicated for treating mixed bacterial and protozoal infections, including diarrhea, dysentery, respiratory infections, and other systemic infections caused by susceptible organisms.

Use Lexoziff OZ Suspension only under the guidance of a healthcare professional. Complete the full course of treatment to prevent resistance. Avoid usage in patients with a known allergy to quinolones or nitroimidazole derivatives.

Store in a cool, dry place below 30°C. Protect from light and moisture. Keep out of reach of children. Shake well before use.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation